These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 5884884)

  • 21. [Stimulation of moving-beam therapy and grid size in the electronic calculation of single fields and standard plans of telecobalt therapy].
    Rosenow U; Bode D
    Strahlentherapie; 1971; 141(1):56-63. PubMed ID: 5137505
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of the integral dose absorbed by a patient treated with telecobalt therapy at the orbitron of the Centro de Oncología y Medicina Nuclear of the Hospital de San Juan de Dios in Madrid, based on a study of the radiation beam].
    Olivares Múñoz MP
    Acta Oncol (Madr); 1964; 3(2):244-50. PubMed ID: 5826852
    [No Abstract]   [Full Text] [Related]  

  • 23. [In vivo dosage in telecobalt treatment of lymph nodes].
    Taskinen PJ; Kiviniitty K
    Nord Med; 1971 Aug; 85(31):940. PubMed ID: 5569716
    [No Abstract]   [Full Text] [Related]  

  • 24. [Palliative telecobalt therapy in lung carcinoma].
    Zieliński T; Karnicka-Mlodkowska H; Kobierska A; Jungowska A
    Pol Tyg Lek; 1973 May; 28(18):651-4. PubMed ID: 4122345
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of field size, field shape, and source-to-skin distance upon the dose rate in fixed field telecobalt therapy.
    Anttila P; Spring E
    Strahlentherapie; 1968 Feb; 135(2):181-5. PubMed ID: 5670503
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preliminary results of tangential arc irradiation in telecobalt therapy of cancer of the breast].
    Abbatucci JS; Robillard J; Bloquel J; Jacob P
    J Radiol Electrol Med Nucl; 1967; 48(6):409-15. PubMed ID: 6063731
    [No Abstract]   [Full Text] [Related]  

  • 27. [Analysis of the influence of chronological factors upon the results obtained with telecobalt as sole therapy in stage 3 cancers of the cervix].
    Abbatucci JS; Roussel A; Quint R
    Ann Radiol (Paris); 1972; 15(7):603-8. PubMed ID: 5077062
    [No Abstract]   [Full Text] [Related]  

  • 28. [On telecobalt irradiation of malignant lymphomas (Hodgkin's disease, lymphoreticulosarcoma) based on 1000 patients].
    Gyenes G
    Radiobiol Radiother (Berl); 1967; 8(4):401-11. PubMed ID: 4882935
    [No Abstract]   [Full Text] [Related]  

  • 29. [An original discontinuous palliative radiotherapy of hepatic metastasis. 1st results].
    Amalric R; Altschuller C; Pollet JF; Spitalier JM
    J Radiol Electrol Med Nucl; 1973 Feb; 54(2):172-3. PubMed ID: 4124180
    [No Abstract]   [Full Text] [Related]  

  • 30. [Telecobalt therapy in cancer of the bladder (presentaion of our experience and analysis of results)].
    Tafalla JJ; Olivares MP; Coutiño PA; Martínez V
    Acta Oncol (Madr); 1966; 5(1):1-26. PubMed ID: 5989492
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical viewpoints on the radiation protection of patients and personnel during application of telecurie units].
    Franke HD
    Strahlenschutz Forsch Prax; 1968; 8():49-71. PubMed ID: 5761392
    [No Abstract]   [Full Text] [Related]  

  • 32. [Future possibilites and usefulness of telecobalt radiation alone in the preoperative treatment of uterine neoplasms. Anatomo-clinical contribution].
    Laddaga M; Calderazzi A; Sargenti A
    Radiol Med; 1968 Jul; 54(7):666-89. PubMed ID: 5191222
    [No Abstract]   [Full Text] [Related]  

  • 33. [Surface doses and mathematical expressions for dose calculation in build-up regions for various telecobalt units and linear accelerators].
    Onai Y; Trifune T; Tomaru T; Uchida I
    Nihon Igaku Hoshasen Gakkai Zasshi; 1972 Dec; 32(9):735-43. PubMed ID: 4510852
    [No Abstract]   [Full Text] [Related]  

  • 34. TELECOBALT TREATMENT OF CARCINOMA OF THE BLADDER.
    VAN DER WERF MESSINGB
    Clin Radiol; 1965 Apr; 16():165-72. PubMed ID: 14272528
    [No Abstract]   [Full Text] [Related]  

  • 35. [Physical problems of telecobalt therapy in laryngeal tumors].
    Fuchs G
    Radiobiol Radiother (Berl); 1969; 10(6):737-41. PubMed ID: 5379963
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the therapeutic results of linear x-ray, telecobalt gamma-ray and betatron therapy in internal medicine].
    Tsuya A; Kaneta K; Okano S; Goto H; Kamata R
    Naika; 1968 Sep; 22(3):713-21. PubMed ID: 5708438
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long term results of telecobalt therapy of malignant bladder tumors].
    Savino G
    Minerva Radiol; 1968 Dec; 13(12):793-7. PubMed ID: 5743159
    [No Abstract]   [Full Text] [Related]  

  • 38. [Telecobalt irradiation of bladder carcinoma with refeence to dose distribution].
    Gyenes G
    Radiobiol Radiother (Berl); 1969; 10(6):715-8. PubMed ID: 5379962
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with and method of the motion technic of tele-cobalt radiation therapy].
    Stender HS; Hagemann G
    Strahlentherapie Sonderb; 1965; 61():169-75. PubMed ID: 5827117
    [No Abstract]   [Full Text] [Related]  

  • 40. [Accuracy of representation of electronically calculated wedge fields in telecobalt therapy].
    von Zwehl D; Rosenow U
    Strahlentherapie; 1971; 141(1):32-7. PubMed ID: 5137502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.